Journal article
Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis
Abstract
OBJECTIVES: The structured, clinically supervised withdrawal of medicines, known as deprescribing, is one strategy to address inappropriate polypharmacy. This study aimed to evaluate the costs and consequences of deprescribing in frail older people living in residential aged care facilities (RACFs) in Australia.
DESIGN: A within-trial cost-consequence analysis of a deprescribing intervention-Opti-Med. The Opti-Med double-blind randomized …
Authors
Okafor CE; Keramat SA; Comans T; Page AT; Potter K; Hilmer SN; Lindley RI; Mangin D; Naganathan V; Etherton-Beer C
Journal
Journal of the American Medical Directors Association, Vol. 25, No. 3, pp. 539–544.e2
Publisher
Elsevier
Publication Date
3 2024
DOI
10.1016/j.jamda.2023.12.016
ISSN
1525-8610